LKLeonid M. Krasnov

Leonid M. Krasnov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leonid M. Krasnov has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Features of Asymptomatic Pheochromocytoma/Paraganglioma Based on Clinical-Laboratory Examination and Computed Tomography

    by D. V. Rebrova, S. N. Fogt, R. A. Chernikov, I. V. Sleptsov, E. A. Fedorov, I. K. Chinchuk, Sh. Sh. Shikhmagomedov, N. V. Vorokhobina, E. A. Zgoda, A. A. Semenov, et al.

    BACKGROUND : Although pheochromocytomas and paragangliomas (PPGLs) classically present with distinct clinical signs, there is a category of patients with asymptomatic disease course. Despite the absence of clinical manifestations, these patients retain the risk of life-threatening hypertensive crisis and other cardiovascular complications. The clinical, laboratory, and imaging characteristics of asymptomatic PPGLs remain insufficiently studied and are of significant scientific and practical interest. AIM : To analyze the clinical, laboratory, and imaging characteristics of asymptomatic PPGLs compared to symptomatic ones. MATERIALS AND METHODS : The analysis included 347 patients with histologically confirmed PPGL who underwent surgery at the Saint Petersburg State University Hospital. Retrospective analysis encompassed demographic data, medical history (primary and comorbid conditions), laboratory findings, and computed tomography (CT) data. RESULTS: The PPGLs patient cohort included 45 cases without clinical signs of catecholamine hypersecretion. The asymptomatic subgroup, compared to symptomatic patients, exhibited younger age (43 [33; 51] vs. 48 [37; 57] years); smaller maximum tumor size (34 [27; 53] vs. 45 [34; 60] mm); lower metanephrine/normetanephrine ratio (0.29 [0.10; 0.79] vs. 0.51 [0.09; 1.23]). CT imaging revealed slightly higher radiodensity values in asymptomatic PPGLs during arterial, venous, and delayed phases compared to symptomatic tumors. However, absolute and relative washout percentages did not differ significantly. CONCLUSION : The younger age and smaller tumor size in asymptomatic PPGL patients suggest earlier detection of the disease compared to symptomatic cases. The lower metanephrine/normetanephrine ratio may indicate a higher prevalence of the norepinephrine-secreting phenotype in asymptomatic PPGLs. No pronounced differences were found in imaging characteristics between asymptomatic and symptomatic tumors.

  • Open Access

    Pheochromocytoma in Neurofibromatosis Type 1

    by D. V. Rebrova, O. I. Loginova, S. L. Nepomnyashchaya, A. R. Bakhtiyarova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, Sh. Sh. Shikhmagomedov, E. N. Imyanitov, et al.

    Neurofibromatosis type 1 is a hereditary disease with a wide variability of clinical manifestations, from the almost complete absence of typical symptoms to a multisystem lesion of the body. One of the possible clinical manifestations of this pathology is a pheochromocytoma — a tumor of the adrenal gland with the possible development of considerable cardiovascular complications. The article describes four cases of patients with pheochromocytoma as part of familial neurofibromatosis type 1, differing in clinical course from asymptomatic form to vivid paroxysmal manifestations. At the same time, the presence and degree of arterial hypertension did not correlate with the level of metanephrines and the size of the pheochromocytoma. 3 out of 4 patients have a hereditary history of neurofibromatosis type 1. In 1 out of 4 cases, simultaneous bilateral damage to the adrenal glands was noted, while the radiation characteristics of pheochromocytomas, both with computed tomography and CT/PET with 18-FDG, differed from the "classic" ones. An objective examination with the identification of "erased" signs of neurofibromatosis type 1 made it possible to establish the diagnosis of bilateral pheochromocytoma even with questionable laboratory and imaging data. Knowledge of clinical manifestations, timely diagnosis of neurofibromatosis type 1, comprehensive treatment and subsequent regular monitoring of patients, as well as examination of blood relatives can significantly improve prognosis and survival.


  • Rhabdomyolysis as a dangerous complication of primary hyperaldosteronism

    by D. V. Rebrova, S. L. Nepomnyashchaya, V. F. Rusakov, E. A. Fedorov, L. M. Krasnov, A. R. Bakhtiyarova, O. I. Loginova, R. A. Chernikov, I. V. Sleptsov

    Rhabdomyolysis is a rare, dangerous complication of primary hyperaldosteronism (PHA) induced by hypokalemia. PHA is underdiagnosed because it does not have a specific, easily identifiable feature and clinicians can be poorly aware of the disease. Prompt diagnosis of PHA and the use of targeted treatment strategies mitigate aldosterone-specific target organ damage, such as rhabdomyolysis. Progressive muscle weakness, as the main symptom of the development of muscle damage, is a reason to monitor electrolyte balance. We present a detailed description of two cases of rhabdomyolysis with hypokalemia. Patient 1, 45 y.o., with an increase in blood pressure (BP) to 220/120 mmHg, which could not be corrected against the background of 3-component antihypertensive therapy, with complaints of headaches, dizziness, sweating, severe muscle weakness of the extremities, muscle pain, was acutely admitted to the hospital, where creatine phosphokinase (CPK) 17204 IU/l (up to 145), CPKMB 205 IU/L (up to 24), AST 889 U/L (up to 35), ALT 232 U/L (up to 40), blood potassium 2.0 mmol/L (3.3–5.5). Neurologist, rheumatologist excluded pathology. Aldosteroma of the right adrenal gland was detected with normalization of BP and potassium levels after adrenalectomy. Patient 2, 55 y.o., with an increased BP of 200/110 mmHg, general and muscular weakness, severe pain in the muscles and joints of the extremities, shortness of breath during physical exertion, heart arrhythmia, was observed for 6 years by a cardiologist, neurologist, rheumatologist, with repeated hospitalizations, including for about rhabdomyolysis. Despite recurrent hypokalemia, the adrenal gland examination was performed only after consultation with an endocrinologist due to loss of consciousness in case of hypoglycemia. The examination revealed primary hyperparathyroidism, bilateral PHA, non-toxic nodular goiter, pituitary microadenoma. Hypoglycemia was not achieved in the 72-hour fasting trial. Multiple endocrine neoplasia type 1 syndrome has been established clinically. In the available literature in Russian and in English, we have found the description of less than 40 similar case reports. A detailed description of those cases is also provided.

  • Open Access

    Comparison of intraoperative hemodynamics in classical and single-port adrenalectomy

    by Sh. Sh. Shikhmagomedov, D. V. Rebrova, M. A. Alekseev, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, R. A. Chernikov, V. F. Rusakov, I. V. Sleptsov, I. V. Sablin, et al.

    BACKGROUND: Pheochromocytoma (PCC) is a tumor from the chromaffin tissue of the adrenal medulla, capable of hyperproduction of catecholamines. An important feature of pheochromocytoma, due to its hormonal activity, is the threat of sudden changes in hemodynamic parameters during surgical treatment. Retroperitoneoscopic access is currently becoming increasingly popular in the surgical treatment of chromaffin tumors of the adrenal glands. In clinical practice, two variants of the mentioned access are used: classic (three-port) and single-port. In this study, the influence of these options of retroperitoneoscopic access on intraoperative hemodynamic control was evaluated.AIM: Comparison of treatment results and intraoperative hemodynamic parameters of patients with adrenal pheochromocytomas operated with single-port and three-port retroperitonescopic access options.MATERIALS AND METHODS: A retrospective single-center cohort study was conducted on a sample of patients initially operated for pheochromocytoma at the Pirogov St. Petersburg State University High Medical Technology Clinic from October 2015 to February 2020 with intraoperative invasive hemodynamic control using PiCCO+ systems.RESULTS: 47 patients were examined, 24 of whom underwent single–port adrenalectomy (included in the first group), 23 — three-port (second group). The average tumor size in the second group was larger (40.12±9.3 and 56.7±21.5, p0.05). Intraoperative consumption of antihypertensive drugs during the release of the adrenal gland and vasopressor drugs after compression of the central vein of the adrenal gland were similar. Blood pressure after compression of the central vein in the first and second groups did not differ significantly (p>0.05). No deaths and postoperative complications were registered in both groups.CONCLUSION: Single-port modification of retroperitoneoscopic access with sufficient experience of the anesthesiological team and the operating surgeon does not lead to deterioration of hemodynamic control and operation results, being safe and effective in the surgical treatment of pheochromocytoma.


  • Open Access

    Adrenocortical Cancer. Results of Examination of Patients at the Clinic of High Medical Technologies

    by Дина Владимировна Реброва, Илья Валерьевич Слепцов, Роман Анатольевич Черников, Игорь Константинович Чинчук, Владимир Федорович Русаков, Леонид Михайлович Краснов, Елисей Александрович Федоров, Арсений Андреевич Семенов, Татьяна Вячеславовна Савельева, Ольга Ивановна Логинова, et al.

    Materials and Methods. The article describes the results of the examination of 76 patients with adrenocortical cancer (ACC), who have undergone surgery in the in-patient facility of the N.I. Pirogov Clinic of High Medical Technologies of St. Petersburg State University. ACC was diagnosed from 2009 to 2020. Patient demographic data, baseline disease characteristics, tumor hormonal activity, and computed tomography (CT) data were described. Results. Overall, the data obtained were consistent with the international literature with respect to age at onset of the disease (median age 45 years), the ratio of females to males (3:1), and the incidence of hypercortisolism (48.8 %). It was found that the combination of radiographic density ≤ 20 HU and mass size less than 4 cm does not exclude all cases of ACC. According to the findings 2 (3.3 %) of 65 patients would not be diagnosed if the above criteria had been used. Within the CT data analysis, about one-third of patients showed no increase in the standard thresholds for absolute and relative percentage washout (RPW) that defines malignancy. The results analysis revealed that the subgroup of patients with Cushing syndrome had a statistically significant increase in contrast washout rates. Conclusion. Overall, the findings in ACC patients in the studied population are consistent with the literature data. The study results suggest that the diagnostic value of contrast washout parameters for differential diagnosis of ACC is limited, especially in patients with small tumors and with Cushing syndrome. According to the data obtained, the most reliable criterion for excluding ACR is native tumor radiodensity < 10 HU; the use of this criterion made it possible to exclude all cases of ACC. Материалы и методы. В настоящей статье приведено описание результатов обследования 76 пациентов с адренокортикальным раком (АКР), прооперированных в стационаре Петербургского государственного университета. Диагноз АКР был установлен с 2009 по 2020 гг. Описаны демографические характеристики пациентов, основные характеристики заболевания, гормональная активность опухоли, данные компьютерной томографии (КТ). Результаты. В целом получены данные, согласующиеся с международной литературой, в отношении возраста при дебюте заболевания (медиана возраста — 45 лет), соотношения лиц женского и мужского пола (3:1), частоты гиперкортизолизма (48,8 %). Обнаружено, что сочетание рентгенологической плотности ≤ 20 HU и размера новообразования менее 4 см не исключает все случаи АКР, согласно полученным данным, у 2 (3,3 %) из 65 пациентов при использовании указанных критериев заболевание было бы пропущено. В рамках анализа данных КТ примерно у трети пациентов не обнаружено повышения стандартных порогов абсолютного и относительного процентов вымывания контраста для определения злокачественности опухоли. При анализе результатов было обнаружено, что в подгруппе пациентов с манифестным синдромом Иценко — Кушинга, при сравнении с остальными, имеет место статистически значимое повышение показателей вымывания контраста. Заключение. В целом полученные данные у пациентов с АКР в исследованной популяции согласуются с литературными. Результаты исследования свидетельствуют о том, что диагностическая ценность определения показателей вымывания контраста для дифференциальной диагностики АКР ограничена, особенно при небольших размерах новообразования и при синдроме Иценко - Кушинга. Согласно полученным данным, наиболее надежным критерием исключения АКР является нативная рентгенологическая плотность < 10 HU, использование этого критерия позволило исключить АКР во всех случаях.

  • Open Access

    Metastatic pheochromocytoma in multiple endocrine neoplasia type 2A

    by D. V. Rebrova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, N. V. Vorokhobina, S. S. Shikhmagomedov, A. A. Semenov, R. A. Chernikov, I. V. Sleptsov, et al.

    Pheochromocytoma (PHEO) currently is considered to be malignant due to metastatic potential. One of the most common familial forms of PHEO is multiple endocrine neoplasia syndrome (MEN) type 2. The penetrance of PHEO in MEN2 syndrome is up to 50% of cases. It may be one- or two-sided, but metastases occur extremely rare. The fact that in majority of cases of MEN2 syndrome the source of distant metastases is medullary thyroid carcinoma (MTC) complicates differential diagnosis in case of PHEO metastasis.Isolated cases of PHEO with metastases to the lymph nodes, lungs, liver, bones, brain in MEN2 patients were described. In the available literature, we have found a description of 31 cases of metastatic PHEO in MEN2 syndrome. The available data of those cases is presented as a table in the article.We present a description of a 40-year-old woman with MEN2A syndrome (mutation of the RET proto-oncogene p.Cys634Tyr), with a history of twice-performed surgical treatment of MTC, with daily crises of arterial hypertension accompanied by vegetative symptoms, with a giant bilateral PHEO (up to 200 m on the right and up to 150 mm on the left) with synchronous large metastasis (up to 50 mm) into the pubic bone with the destruction. The patient underwent several surgeries: bilateral adrenalectomy, then a bilateral revision of the neck, removal of the right upper and right lower parathyroid glands, residual thyroid tissue, then resection of the right pubic bone with a tumor.

  • Open Access

    Case reports of diagnosis and treatment of adrenal tumors complicated by rupture and formation of retroperitoneal hematoma

    by S. L. Nepomnyashchaya, E. A. Fedorov, L. M. Krasnov, D. V. Rebrova, Y. V. Semiletova, I. A. Pavlikova, A. R. Bakhtiyarova, V. N. Danilin, V. V. Dmitrichenko, O. V. Kuleshov, et al.

    This article presents different variants of the clinical course of complications of adrenal tumors with rupture and formation of retroperitoneal hematomas, depending on the morphological characteristics of the neoplasms. The first clinical case described a 38-year-old patient with adrenocortical carcinoma of the left adrenal gland up to 8 cm in size, complicated by rupture with the formation of a retroperitoneal hematoma with a volume of 2800 cm3 , simulating a giant extraorgan retroperitoneal tumor with anemia and cachexia. After surgical treatment and stabilization of the condition, the patient is referred for chemotherapy with a positive outcome. The second case is about a 21-year-old patient with undiagnosed pheochromocytoma, who had a tumor rupture with hemorrhage and the development of acute symptoms against the background of the start of antihypertensive therapy. After the retroperitoneoscopic adrenalectomy, the condition stabilized. The third case is about the experience of observing a 45-year-old patient with myelolipoma up to 6.4 cm, complicated by a previously suffered retroperitoneal hematoma, in whom surgical treatment was not performed due to the presence of end-stage chronic kidney disease and stable tumor condition.

  • Open Access

    Corticotropin-producing pheochromocytoma in multiple endocrine neoplasia type 1

    by D. V. Rebrova, S. I. Grigorova, N. V. Vorokhobina, E. A. Zgoda, K. Yu. Novokshonov, S. G. Feofanova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, et al.

    A clinical case of a man 66 y.o. who was diagnosed with hormone-inactive pituitary macroadenoma complicated by corneal erosion and partial atrophy of the optic nerve of the left eye due to exophthalmos. The increase in prolactin level was regarded due to a «stalk-effect». The patient underwent a transnasal pituitary adenomectomy with subsequent regression of symptoms. After 4 years, against the background of a new coronavirus infection, increasing general weakness, headaches, a crisis increase in blood pressure and tachycardia attacks appeared. Computed tomography (CT) accidentally revealed an adrenal incidentaloma, in laboratory tests — hypercortisolism, elevated ACTH levels, hypokalemia, hyperglycemia, increased levels of metanephrine and normetanephrine. The patient developed acute steroid psychosis, after which an adrenalectomy with a tumor was performed, a pheochromocytoma was histologically confirmed. After surgery, there was a regression of symptoms, the development of adrenal insufficiency with reduced levels of ACTH and cortisol. Upon further examination, a polynodose euthyroid goiter was established, the biopsy of the nodes — Hashimoto’s thyroiditis (Bethesda II). Meanwhile, primary hyperparathyroidism was detected. According to ultrasound, scintigraphy with Ts99m-Technetril and CT revealed an increase of left parathyroid gland. A bilateral revision of the neck, removal of the right upper and left upper parathyroid adenomas were performed. In the postoperative period, the levels of calcium and parathyroid hormone were normalized. Given the presence of a combination of multiple tumors of the endocrine system (primary hyperparathyroidism, corticotropin-producing pheochromocytoma, hormone-inactive pituitary macroadenoma, polynodose euthyroid goiter), the MEN1 syndrome was clinically established. The study of 2 and 10 exons of the MEN1 gene revealed no mutations, which does not exclude the presence of a hereditary syndrome. The patient continues observation. In the available literature in Russian and English languages the case of ACTH pheochromocytoma as part of the MEN type 1 syndrome have not been found. Therefore, we consider the presented case to be the first one.


  • Open Access

    Surgical treatment of pheochromocytoma

    by Sh. Sh. Shikhmagomedov, D. V. Rebrova, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, R. A. Chernikov, V. F. Rusakov, I. V. Slepstov, E. A. Zgoda

    This review article contains a summary of modern aspects of preoperative preparation, surgical treatment, and follow-up of patients with adrenal pheochromocytomas. The main component of preoperative preparation is the use of alpha-blockers. The need to prescribe them to all patients is increasingly disputed, especially for patients without severe hypertension. An increasing number of publications demonstrate positive results of treatment without the use of alpha-blockers, advocating an individual approach and the use of the drug according to certain indications. Minimally invasive endoscopic techniques of adrenalectomy have become widespread in surgical treatment. They are represented by laparoscopic and retroperitonescopic technic, including using their single-port modifications. The earliest possible intersection of the central vein in the past was considered the most important aspect of adrenalectomy for pheochromocytoma, currently, due to the development of surgical techniques and anesthesiological manuals, this has ceased to be a mandatory rule of successful surgery. Despite the significant influence of the intersection of this vessel on intraoperative hemodynamics, surgical tactics with its later intersection have their own justifications and do not lead to a deterioration in treatment results. The standard volume of surgical intervention for pheochromocytomas is total adrenalectomy, however, in the presence of hereditary syndromes, such as multiple endocrine neoplasia type 2 syndrome, neurofibomatosis type 1, von Hippel-Lindau syndrome, it is possible to perform cortical-sparing adrenalectomy.


  • Open Access

    Comparison of the effectiveness of various methods for determining the level of metanephrines in the diagnosis of pheochromocytomas

    by Sh. Sh. Shikhmagomedov, D. V. Rebrova, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, R. A. Chernikov, V. F. Rusakov, I. V. Slepstov, E. A. Zgoda

    BACKGROUND: Pheochromocytoma (PHEO) is a tumor from the chromaffin tissue of the adrenal medulla, capable of hyperproduction of catecholamines. The increased production of hormones by the tumor leads to catecholamine crises, which have a pathological effect on all organs and systems. In the primary diagnosis of pheochromocytomas, it is important to determine the level of the metabolite of catecholamines — metanephrines. Currently, in clinical practice, various methods are used to determine the level of this metabolite: in blood plasma or in urine, total or only free form, fractionated analysis or unfractionated.AIM: Comparison of the effectiveness of various methods for determining the level of metanephrines for the diagnosis of pheochromocytomas.MATERIALS AND METHODS: A retrospective single-center cohort study was conducted on a sample of patients who were initially operated on for adrenal neoplasm at the Pirogov St. Petersburg State University High Medical Technology Clinic from November 2007 to December 2022 and who passed analysis to determine the level of blood or urine metanephrins before surgical treatment. The results of tests for metanephrine and tumor size were evaluated.RESULTS: 1088 patients with adrenal neoplasms who underwent surgical treatment were examined, of which 348 had histologically confirmed the presence of pheochromocytoma. Four types of metanephrine assays were compared: free fractionated plasma metanephrines (232 patients), unfractionated daily urine metanephrines (431 patients), fractionated total daily urine metanephrines (427 patients) and fractionated free daily urine metanephrines (178 patients). The greatest sensitivity was demonstrated by the analysis of free fractionated plasma methanephrines (95.4%). Unlike others, the sensitivity of this analysis did not decrease in the group of patients with small pheochromocytomas (3 cm or less). The greatest specificity was demonstrated by the analysis of unfractionated metanephrines in daily urine (97.8%), with the lowest sensitivity among all tests (67.6%). The study of fractionated total daily urine metanephrins showed good results of sensitivity and specificity, only slightly inferior to the best indicators, and the analysis of free daily urine metanephrins demonstrated unexpectedly low efficiency. There is a positive correlation between the level of metanephrine in the blood and the size of the tumor.CONCLUSION: Based on the data obtained, the preferred assays for the primary diagnosis of pheochromocytoma can be considered the determination of fractionated free plasma metanephrines and fractionated total daily urine metanephrines, which is consistent with relevant clinical recommendations. It was found that the size of the tumor correlates with the severity of an increase in the level of metanephrins determined by any of the described methods.